Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02230306
Title Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hussein Tawbi
Indications

melanoma

Therapies

Cobimetinib + Vemurafenib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST